![](/img/cover-not-exists.png)
Phase II Clinical Evaluation of Etoposide (VP-16-213, Vepesid®) as a Second-Line Treatment in Ovarian Cancer
Eckhardt, Sá, ndor, Herná, di, Zoltá, n, Thurzó, , Lá, szló, , Telekes, A., Sopkova, Bozena, Mechl, Zdenek, Pawlicki, Marek, Kerpel-Fronius, Sá, ndorVolume:
47
Year:
1990
Journal:
Oncology
DOI:
10.1159/000226835
File:
PDF, 2.51 MB
1990